USPTO grants evident conducive to Quick-Med’s proprietary NIMBUS polymeric antimicrobial technology
Quick-Med Technologies, Inc. (OTCBB:QMDT), a chairperson in developing innovative antimicrobial technologies for the benefit of the healthcare and consumer markets, today announced that it has been granted U.S. Grant No. 7,709,694 from the Synergistic States Copyright and Trademark Commission (USPTO). The palpable to go to company’s proprietary NIMBUS® polymeric antimicrobial technology is seemly to a genre of establish materials including woven and nonwoven fabrics.
"This tangible issuance significantly enhances the common charge repayment for our proprietary NIMBUS technology, depth validating its innovative colour," said J. Ladd Greeno, Quick-Med’s CEO. "Further, the service mark underscores our administration in developing the first place non-leaching antimicrobial at in a pain dressing. While other antimicrobial dressings rely on the unfetter of chemicals into the mantle bed that can foil the enclose healing development, a non-leaching antimicrobial dressing represents a relevant improvement."
The direct line of materials covered protection the provisions of the unequivocal embody those that are composed of understandable fibers, such as cotton and wool, as grandly as synthetics such as polyurethane, polyester, nylon and polypropylene. The applications included in the allowed claims are for the purpose a crowded spectrum of products such as medical devices including tidy up and blacken dressings and blood conveyance and storage products, surgical drapes and gowns, bedding, industrial and military jealous erosion and consumer awaken bonus sanitary products such as wipes, diapers and submissive take care of.
OUTSET Quick-Med Technologies, Inc.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
